Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. The difluoromethyl group enhances metabolic stability and binding affinity, while the overall structure allows for selective modification, making it valuable in creating compounds with high biological activity. The bromo and amine groups enable cross-coupling reactions, facilitating the construction of complex molecules in medicinal chemistry. Also employed in agrochemical research for designing novel pesticides.